Last reviewed · How we verify
Psilocybin and D-Serine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Psilocybin and D-Serine (Psilocybin and D-Serine) — Hadassah Medical Organization.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Psilocybin and D-Serine TARGET | Psilocybin and D-Serine | Hadassah Medical Organization | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Psilocybin and D-Serine CI watch — RSS
- Psilocybin and D-Serine CI watch — Atom
- Psilocybin and D-Serine CI watch — JSON
- Psilocybin and D-Serine alone — RSS
Cite this brief
Drug Landscape (2026). Psilocybin and D-Serine — Competitive Intelligence Brief. https://druglandscape.com/ci/psilocybin-and-d-serine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab